Consistent with the in vitro results, K-RasLA1 transgenic mice experiments also showed that delivery miR-199b can significantly inhibit ERK and Akt signaling activation and induce cancer cell apoptosis (Fig. 5b). This evidence concerns the gene AKT1 and cancer.